Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Amicus Therapeutics (FOLD) Gross Profit (2016 - 2025)

Amicus Therapeutics filings provide 10 years of Gross Profit readings, the most recent being $158.7 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 17.64% to $158.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $561.3 million, a 18.08% increase, with the full-year FY2025 number at $561.3 million, up 18.08% from a year prior.
  • Gross Profit hit $158.7 million in Q4 2025 for Amicus Therapeutics, up from $149.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $158.7 million in Q4 2025 to a low of $59.9 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $89.5 million (2023), compared with a mean of $98.0 million.
  • Biggest five-year swings in Gross Profit: rose 0.6% in 2022 and later surged 37.07% in 2024.
  • Amicus Therapeutics' Gross Profit stood at $74.3 million in 2021, then rose by 5.93% to $78.7 million in 2022, then surged by 31.82% to $103.8 million in 2023, then rose by 29.99% to $134.9 million in 2024, then increased by 17.64% to $158.7 million in 2025.
  • The last three reported values for Gross Profit were $158.7 million (Q4 2025), $149.6 million (Q3 2025), and $139.5 million (Q2 2025) per Business Quant data.